DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
36	表皮水疱症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00987142 (ClinicalTrials.gov)	December 2006	29/9/2009	Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa	A Comparative Open-Label Multicentre Clinical Trial To Assess The Efficacy And Safety Of A New Therapy With Cultured Chimeric Skin For The Treatment Of Skin Lesions In Patients With Epidermolysis Bullosa	EPIDERMOLYSIS BULLOSA	Drug: CX501;Device: Occlusive non adherent dressing	Tigenix S.A.U.	NULL	Completed	N/A	N/A	All	12	Phase 2	Spain

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00987142
(ClinicalTrials.gov)

December 2006

29/9/2009

Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa

A Comparative Open-Label Multicentre Clinical Trial To Assess The Efficacy And Safety Of A New Therapy With Cultured Chimeric Skin For The Treatment Of Skin Lesions In Patients With Epidermolysis Bullosa

EPIDERMOLYSIS BULLOSA

Drug: CX501;Device: Occlusive non adherent dressing

Tigenix S.A.U.

NULL

Completed

N/A

All

Phase 2

Spain